Effect of tiomolibdate choline on copper balance in patients with Wilson disease: An open-label phase 2 trial

Aftab Ala, Thomas D. Sandahl, Karl H. Weiss, Valentina Medici, Chandler D. Robinson, Andrew Cittadine, Declan Tuffy, Edward Gane, Fred K. Askari

Open source

DOI
10.1097/hc9.0000000000000971
Published
2026-05-19
Container
Hepatology Communications
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/hc9.0000000000000971,
  title = {Effect of tiomolibdate choline on copper balance in patients with Wilson disease: An open-label phase 2 trial},
  author = {Aftab Ala and Thomas D. Sandahl and Karl H. Weiss and Valentina Medici and Chandler D. Robinson and Andrew Cittadine and Declan Tuffy and Edward Gane and Fred K. Askari},
  year = {2026},
  journal = {Hepatology Communications},
  doi = {10.1097/hc9.0000000000000971},
  url = {https://doi.org/10.1097/hc9.0000000000000971}
}

RIS

TY  - JOUR
TI  - Effect of tiomolibdate choline on copper balance in patients with Wilson disease: An open-label phase 2 trial
AU  - Aftab Ala
AU  - Thomas D. Sandahl
AU  - Karl H. Weiss
AU  - Valentina Medici
AU  - Chandler D. Robinson
AU  - Andrew Cittadine
AU  - Declan Tuffy
AU  - Edward Gane
AU  - Fred K. Askari
PY  - 2026
JO  - Hepatology Communications
DO  - 10.1097/hc9.0000000000000971
UR  - https://doi.org/10.1097/hc9.0000000000000971
ER  - 

APA

Ala, A., Sandahl, T. D., Weiss, K. H., Medici, V., Robinson, C. D., Cittadine, A., Tuffy, D., Gane, E., & Askari, F. K. (2026). Effect of tiomolibdate choline on copper balance in patients with Wilson disease: An open-label phase 2 trial. Hepatology Communications. https://doi.org/10.1097/hc9.0000000000000971

Source records